4 NASH Clinical Trials in Flagstaff, AZ (2026)

Q: How do I join a clinical trial in Flagstaff?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Flagstaff research site will contact you.

Recruiting NASH Studies in Flagstaff

NCT06215716Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The stud...

Flagstaff, AZ1,650 participantsAkero Therapeutics, Inc

View Study Details

NCT06318169Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult participants with MASH (previously known as nonalcoholic stea...

Flagstaff, AZ1,350 participants89bio, Inc.

View Study Details

NCT06419374Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH \[previously known as nonalco...

Flagstaff, AZ762 participants89bio, Inc.

View Study Details

NCT05519475Recruiting

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

This study is researching an investigational drug, ALN-HSD called "study drug". This study is focused on participants who are known to have metabolic dysfunction-associated steatohepatitis (MASH). MAS...

Flagstaff, AZ120 participantsRegeneron Pharmaceuticals

View Study Details

About NASH Clinical Trials in Flagstaff

Nonalcoholic steatohepatitis (NASH/MASH) is a form of fatty liver disease involving liver inflammation and damage caused by fat buildup, not related to alcohol use. It can progress to fibrosis, cirrhosis, and liver failure. Treatment focuses on weight loss, lifestyle changes, and emerging pharmacological therapies.

There are currently 4 nash clinical trials recruiting participants in Flagstaff, AZ. These studies are seeking a combined 3,882 participants. Research is being sponsored by Akero Therapeutics, Inc, 89bio, Inc., Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

NASH Clinical Trials in Flagstaff — FAQ

Are there nash clinical trials in Flagstaff?

Yes, there are 4 nash clinical trials currently recruiting in Flagstaff, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Flagstaff?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Flagstaff research site will contact you about next steps.

Are clinical trials in Flagstaff free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Flagstaff studies also compensate for your time and travel.

What nash treatments are being tested?

The 4 active trials in Flagstaff are testing new therapies including novel drugs, biologics, and treatment approaches for nash.

Data updated July 13, 2026 from ClinicalTrials.gov